Polymyxin B Injection, Powder, Lyophilized, For Solution
Product Images NDC 68083-174

This appears to be a chemical formula or structure for Polymyxin B which is a type of antibiotic that is used to treat bacterial infections. It is composed of various amino acids and structural elements indicated by the symbols and characters.*

Polymyxin B Sulfate is a medication that is solely available by prescription (Rx only) and is administered by the intramuscular, intravenous, or intrathecal route to hospitalized patients. The medication should not exceed dosages of 25,000 units per kg per day, as it may be neuro- and nephrotoxic. One vial contains Polymyxin B Sulfate equivalent to 500,000 polymyxin B units. Before reconstitution, the vial should be stored between 20° to 25°C (68° to 77°F) and after that, the product must be stored under refrigeration, between 2° to 8°C (36° to 46°F), and any unused portion should be discarded after 72 hours. The medication can be harmful and is only for hospital use. Gland Pharma Limited in Hyderabad, India, is the manufacturer of Polymyxin B Sulfate.*

This appears to be a product information label for Polymyxin B Sulfate, an antibiotic medication used in hospitals for intramuscular, intravenous or intrathecal administration. Each vial contains 500,000 units of Polymyxin B Sulfate, and the dosage should not exceed 25,000 units per kg per day. The medication must be stored before reconstitution between 20° and 25°C, and after reconstitution, it must be stored under refrigeration between 2° and 8°C. Any unused portion must be discarded after 72 hours. The label contains additional warnings regarding potential neuro and nephrotoric effects.*